Advertisement
Screener

XBIOTECH INC. (XBIT) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

XBIOTECH INC. Increase (Decrease) in Accounts Payable

XBIOTECH INC. (XBIT) reported Increase (Decrease) in Accounts Payable of -$432.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-13

  • XBIOTECH INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $246.00K, a 25.45% decline year-over-year.
  • XBIOTECH INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$678.00K.
  • XBIOTECH INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $492.00K, a 24.66% decline year-over-year.
  • XBIOTECH INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$385.00K.
  • XBIOTECH INC. increase (decrease) in accounts payable for fiscal 2025 was -$688.00K.
  • XBIOTECH INC. increase (decrease) in accounts payable for fiscal 2024 was -$364.00K, a 500.00% decline from fiscal 2023.
  • XBIOTECH INC. increase (decrease) in accounts payable for fiscal 2023 was $91.00K, a 74.51% decline from fiscal 2022.
  • XBIOTECH INC. increase (decrease) in accounts payable for fiscal 2022 was $357.00K.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2026-06-30$246.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$432.00K
10-Q · filed 2026-08-13
$60.00K
derived: sum of 3 quarters · filed 2026-08-13
-$325.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$678.00K
10-Q · filed 2026-05-14
-$186.00K
derived: sum of 2 quarters · filed 2026-05-14
-$571.00K
derived: sum of 3 quarters · filed 2026-05-14
-$241.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$492.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$107.00K
derived: sum of 2 quarters · filed 2026-03-13
$437.00K
derived: sum of 3 quarters · filed 2026-08-13
-$688.00K
10-K · filed 2026-03-13
2025-09-30-$385.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$55.00K
derived: sum of 2 quarters · filed 2026-08-13
-$1.18M
10-Q · filed 2025-11-12
-$527.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$330.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$795.00K
10-Q · filed 2026-08-13
-$142.00K
derived: sum of 3 quarters · filed 2026-08-13
-$342.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$1.13M
10-Q · filed 2026-05-14
-$472.00K
derived: sum of 2 quarters · filed 2026-05-14
-$672.00K
derived: sum of 3 quarters · filed 2026-05-14
-$1.50M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$653.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$453.00K
derived: sum of 2 quarters · filed 2026-03-13
-$372.00K
derived: sum of 3 quarters · filed 2026-03-13
-$364.00K
10-K · filed 2026-03-13
2024-09-30-$200.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$1.02M
derived: sum of 2 quarters · filed 2025-11-12
-$1.02M
10-Q · filed 2025-11-12
$14.00K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$825.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
-$817.00K
10-Q · filed 2025-08-13
$214.00K
derived: sum of 3 quarters · filed 2025-08-13
-$106.00K
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$8.00K
10-Q · filed 2025-05-14
$1.04M
derived: sum of 2 quarters · filed 2025-05-14
$719.00K
derived: sum of 3 quarters · filed 2025-05-14
$1.16M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$711.00K
derived: sum of 2 quarters · filed 2025-03-18
$1.16M
derived: sum of 3 quarters · filed 2025-03-18
$91.00K
10-K · filed 2025-03-18
2023-09-30-$320.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$124.00K
derived: sum of 2 quarters · filed 2024-11-13
-$940.00K
10-Q · filed 2024-11-13
$158.00K
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$444.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
-$620.00K
10-Q · filed 2024-08-12
$478.00K
derived: sum of 3 quarters · filed 2024-08-12
-$484.00K
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$1.06M
10-Q · filed 2024-05-10
$34.00K
derived: sum of 2 quarters · filed 2024-05-10
-$928.00K
derived: sum of 3 quarters · filed 2024-05-10
$105.00K
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
$136.00K
derived: sum of 2 quarters · filed 2024-03-15
$1.17M
derived: sum of 3 quarters · filed 2024-03-15
$357.00K
10-K · filed 2024-03-15
2022-09-30-$962.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$71.00K
derived: sum of 2 quarters · filed 2023-11-09
-$741.00K
10-Q · filed 2023-11-09
$424.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$1.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
$221.00K
10-Q · filed 2023-08-11
$1.39M
derived: sum of 3 quarters · filed 2023-08-11
$733.00K
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31-$812.00K
10-Q · filed 2023-05-10
$353.00K
derived: sum of 2 quarters · filed 2023-05-10
-$300.00K
derived: sum of 3 quarters · filed 2023-05-10
$83.00K
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$512.00K
derived: sum of 2 quarters · filed 2023-03-15
$895.00K
derived: sum of 3 quarters · filed 2023-03-15
-$514.00K
10-K · filed 2023-03-15
2021-09-30-$653.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$270.00K
derived: sum of 2 quarters · filed 2022-11-09
-$1.68M
10-Q · filed 2022-11-09
-$2.56M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$383.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
-$1.03M
10-Q · filed 2022-08-10
-$1.90M
derived: sum of 3 quarters · filed 2022-08-10
-$4.45M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31-$1.41M
10-Q · filed 2022-05-10
-$2.29M
derived: sum of 2 quarters · filed 2022-05-10
-$4.83M
derived: sum of 3 quarters · filed 2022-05-10
-$5.21M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31-$876.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
-$3.42M
derived: sum of 2 quarters · filed 2022-03-15
-$3.80M
derived: sum of 3 quarters · filed 2022-03-15
-$334.00K
10-K · filed 2022-03-15
2020-09-30-$2.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$2.93M
derived: sum of 2 quarters · filed 2021-11-09
$542.00K
10-Q · filed 2021-11-09
$1.63M
derived: sum of 4 quarters · filed 2022-03-15
2020-06-30-$379.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$3.09M
10-Q · filed 2021-08-09
$4.18M
derived: sum of 3 quarters · filed 2022-03-15
$3.80M
derived: sum of 4 quarters · filed 2022-03-15
2020-03-31$3.47M
10-Q · filed 2021-05-10
$4.56M
derived: sum of 2 quarters · filed 2022-03-15
$4.18M
derived: sum of 3 quarters · filed 2022-03-15
$3.87M
derived: sum of 4 quarters · filed 2022-03-15
2019-12-31$1.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$708.00K
derived: sum of 2 quarters · filed 2022-03-15
$397.00K
derived: sum of 3 quarters · filed 2022-03-15
$496.00K
10-K · filed 2022-03-15
2019-09-30-$380.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$691.00K
derived: sum of 2 quarters · filed 2020-11-09
-$592.00K
10-Q · filed 2020-11-09
$183.00K
derived: sum of 4 quarters · filed 2021-03-16
2019-06-30-$311.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$212.00K
10-Q · filed 2020-08-10
$563.00K
derived: sum of 3 quarters · filed 2021-03-16
-$15.00K
derived: sum of 4 quarters · filed 2021-03-16
2019-03-31$99.00K
10-Q · filed 2020-05-11
$874.00K
derived: sum of 2 quarters · filed 2021-03-16
$296.00K
derived: sum of 3 quarters · filed 2021-03-16
$617.00K
derived: sum of 4 quarters · filed 2021-03-16
2018-12-31$775.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$197.00K
derived: sum of 2 quarters · filed 2021-03-16
$518.00K
derived: sum of 3 quarters · filed 2021-03-16
-$78.00K
10-K · filed 2021-03-16
2018-09-30-$578.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$257.00K
derived: sum of 2 quarters · filed 2019-11-12
-$853.00K
10-Q · filed 2019-11-12
-$1.35M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30$321.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$275.00K
10-Q · filed 2019-08-09
-$768.00K
derived: sum of 3 quarters · filed 2020-03-16
-$1.81M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31-$596.00K
10-Q · filed 2019-05-09
-$1.09M
derived: sum of 2 quarters · filed 2020-03-16
-$2.13M
derived: sum of 3 quarters · filed 2020-03-16
-$1.46M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31-$493.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$1.53M
derived: sum of 2 quarters · filed 2020-03-16
-$865.00K
derived: sum of 3 quarters · filed 2020-03-16
-$2.70M
10-K · filed 2020-03-16
2017-09-30-$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31
-$372.00K
derived: sum of 2 quarters · filed 2018-10-31
-$2.21M
10-Q · filed 2018-10-31
-$1.11M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$668.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$1.17M
10-Q · filed 2018-08-09
-$74.00K
derived: sum of 3 quarters · filed 2019-03-15
-$3.68M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31-$1.83M
10-Q · filed 2018-05-08
-$742.00K
derived: sum of 2 quarters · filed 2019-03-15
-$4.35M
derived: sum of 3 quarters · filed 2019-03-15
-$468.00K
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31$1.09M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15
-$2.52M
derived: sum of 2 quarters · filed 2019-03-15
$1.37M
derived: sum of 3 quarters · filed 2019-03-15
-$981.00K
10-K/A · filed 2019-03-15
2016-09-30-$3.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$274.00K
derived: sum of 2 quarters · filed 2017-11-09
-$2.07M
10-Q · filed 2017-11-09
-$2.36M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$3.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$1.54M
10-Q · filed 2017-08-08
$1.25M
derived: sum of 3 quarters · filed 2018-03-16
$2.23M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31-$2.35M
10-Q · filed 2017-05-10
-$2.63M
derived: sum of 2 quarters · filed 2018-03-16
-$1.65M
derived: sum of 3 quarters · filed 2018-03-16
-$2.39M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31-$284.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$696.00K
derived: sum of 2 quarters · filed 2018-03-16
-$43.00K
derived: sum of 3 quarters · filed 2018-03-16
$840.00K
10-K · filed 2018-03-16
2015-09-30$980.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$241.00K
derived: sum of 2 quarters · filed 2016-11-14
$1.12M
10-Q · filed 2016-11-14
$1.48M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30-$739.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12
$144.00K
10-Q · filed 2016-08-12
$495.00K
derived: sum of 3 quarters · filed 2017-03-16
$782.00K
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$883.00K
10-Q · filed 2016-05-13
$1.23M
derived: sum of 2 quarters · filed 2017-03-16
$1.52M
derived: sum of 3 quarters · filed 2017-03-16
$2.13M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$351.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$638.00K
derived: sum of 2 quarters · filed 2017-03-16
$1.25M
derived: sum of 3 quarters · filed 2017-03-16
$1.07M
10-K · filed 2017-03-16
2014-09-30$287.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
$897.00K
derived: sum of 2 quarters · filed 2015-11-13
$717.00K
10-Q · filed 2015-11-13
2014-06-30$610.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14
$430.00K
10-Q · filed 2015-08-14
2014-03-31-$180.00K
10-Q · filed 2015-06-18
2013-12-31$103.00K
10-K · filed 2016-04-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
HYPERION DEFI, INC. (HYPD)United States$0.065B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95